Cellectar Biosciences (NV40.MU) Q1 2026 Earnings

4MarConfirmed
Q1 2026
-1.05
-0.52
0.02
0.56

Details

Expected EPS
-1.05263609
Actual EPS
0.55861
Surprise EPS
1.61
Surprise Percent
+153.07%

Description

Cellectar Biosciences (NV40.MU) has reported earnings of 0.55861 per share for Q1 2026.

0 Comments

Share your thoughts